Literature DB >> 8399829

In vivo proton magnetic resonance spectroscopy study on premature aging in adult Down's syndrome.

T Murata1, Y Koshino, M Omori, I Murata, M Nishio, T Horie, Y Umezawa, K Isaki, H Kimura, S Itoh.   

Abstract

Proton magnetic resonance spectroscopy (1H-MRS) was performed in a group of 18 adult patients with Down's syndrome (DS) aged 20-46 years, and the peak area ratios (NAA/Cr, Cho/Cr, NAA/Cho) of N-acetylaspartate (NAA), total creatine (Cr), and choline-containing compounds (Cho) calculated separately in the patients in their 20's, 30's, and 40's. In age-matched healthy control groups, there were no significant age-related changes in any of the peak area ratios. In contrast, in the DS group, although the relative amount of NAA (NAA/Cr) showed no significant change with increasing age, the relative amount of Cho (Cho/Cr and NAA/Cho) was significantly increased in the 40's group. At least as judged by MRI, few age-related general morphological changes such as brain atrophy were apparent in the third, fourth, and fifth decade groups. However, the MRI findings considered together with the age-related changes in the peak area ratios suggest that in DS patients in the fifth decade metabolic abnormalities such as degradation and/or rapid synthesis of brain cell membrane may occur prior to neuronal loss and degeneration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399829     DOI: 10.1016/0006-3223(93)90086-s

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  Down's syndrome and the links with Alzheimer's disease.

Authors:  A J Holland; C Oliver
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

2.  Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome.

Authors:  Andreana P Haley; Mitzi M Gonzales; Takashi Tarumi; Steven C Miles; Katayoon Goudarzi; Hirofumi Tanaka
Journal:  Metab Brain Dis       Date:  2010-11-10       Impact factor: 3.584

3.  Serial proton magnetic resonance spectroscopy in a patient with the interval form of carbon monoxide poisoning.

Authors:  T Murata; S Itoh; Y Koshino; M Omori; I Murata; K Sakamoto; K Isaki; H Kimura; Y Ishii
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

Review 4.  Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.

Authors:  Elizabeth Head; David K Powell; Frederick A Schmitt
Journal:  Front Aging Neurosci       Date:  2018-06-21       Impact factor: 5.750

5.  (1)H-MRS metabolites in adults with Down syndrome: Effects of dementia.

Authors:  A-L Lin; D Powell; A Caban-Holt; G Jicha; W Robertson; B T Gold; R Davis; E Abner; D M Wilcock; F A Schmitt; E Head
Journal:  Neuroimage Clin       Date:  2016-06-02       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.